首页> 外文期刊>Antioxidants >The Interaction between Mitochondrial Oxidative Stress and Gut Microbiota in the Cardiometabolic Consequences in Diet-Induced Obese Rats
【24h】

The Interaction between Mitochondrial Oxidative Stress and Gut Microbiota in the Cardiometabolic Consequences in Diet-Induced Obese Rats

机译:线粒体氧化应激和肠道微生物在饮食诱导的肥胖大鼠心脏异常后果的相互作用

获取原文
       

摘要

Background: The objective of this study is to determine the role of mitochondrial oxidative stress in the dysbiosis associated with a high fat diet in rats. In addition, the impact of gut microbiota (GM) in the cardiometabolic consequences of diet-induced obesity in rats has been evaluated. Methods: Male Wistar rats were fed either a high fat diet (HFD) or a control (CT) one for 6 weeks. At the third week, one-half of the animals of each group were treated with the mitochondrial antioxidant MitoTempo (MT; 0.7 mgKg ?1 day ?1 i.p). Results: Animals fed an HFD showed a lower microbiota evenness and diversity in comparison to CT rats. This dysbiosis is characterized by a decrease in Firmicutes/Bacteroidetes ratio and relevant changes at family and genera compared with the CT group. This was accompanied by a reduction in colonic mucin-secreting goblet cells. These changes were reversed by MT treatment. The abundance of certain genera could also be relevant in the metabolic consequences of obesity, as well as in the occurrence of cardiac fibrosis associated with obesity. Conclusions: These results support an interaction between GM and mitochondrial oxidative stress and its relation with development of cardiac fibrosis, suggesting new approaches in the management of obesity-related cardiometabolic consequences.
机译:背景:本研究的目的是确定线粒体氧化应激在与大鼠高脂肪饮食相关的脱敏中的作用。此外,已经评估了肠道微生物肿瘤(GM)对大鼠饮食诱导肥胖症的心脏异构后果的影响。方法:雄性Wistar大鼠喂养高脂肪饮食(HFD)或一种对照(CT)6周。在第三周,每组的一半动物被线粒体抗氧化剂Mitotempo治疗(MT; 0.7 mgkg?1天?1 i.p)。结果:与CT大鼠相比,喂养HFD的动物表现出较低的微生物群均匀性和多样性。与CT组相比,这种消带功能的特征在于,对族和伯爵的比例和家庭和属的相关变化降低。这伴随着结肠粘蛋白分泌脚蛋白细胞的减少。 Mt治疗逆转了这些变化。某些属于肥胖的代谢后果以及与肥胖相关的心肌纤维化发生的情况也可能是相关的。结论:这些结果支持GM和线粒体氧化应激之间的相互作用及其与心肌纤维化的发展的关系,旨在管理肥胖相关的心细镜后果的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号